Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Equivalence trials in SLE research: issues to consider.

M Y Kim1, J P Buyon, M Petri

  • 1Epidemiology and Biostatistics Program, Department of Environmental Medicine, New York University School of Medicine, New York 10016, USA.

Lupus
|November 24, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Collapse of Nuclear Collectivity along the N=Z Line.

Physical review letters·2026
Same author

Author Correction: An asymmetric fission island driven by shell effects in light fragments.

Nature·2025
Same author

An asymmetric fission island driven by shell effects in light fragments.

Nature·2025
Same author

Electromagnetic properties of nuclei from first principles: a case for synergies between experiment and theory.

Philosophical transactions. Series A, Mathematical, physical, and engineering sciences·2024
Same author

Study of the N=32 and N=34 Shell Gap for Ti and V by the First High-Precision Multireflection Time-of-Flight Mass Measurements at BigRIPS-SLOWRI.

Physical review letters·2023
Same author

The clinical and serological associations of hypocomplementemia in a longitudinal sle cohort.

Seminars in arthritis and rheumatism·2020
Same journal

Association of systemic lupus erythematosus with 90-day readmission following heart failure hospitalization: A national readmission database (NRD) analysis, 2016-2017.

Lupus·2026
Same journal

Association of GPX4 rs713041 and rs4807542 polymorphisms and serum GPX4 levels in Chinese patients with systemic lupus erythematosus.

Lupus·2026
Same journal

Giant cell myocarditis in an 18-year-old patient with new-onset systemic lupus erythematosus: A fatal case of rapidly progressing heart failure.

Lupus·2026
Same journal

An evidence-based specialist nursing protocol for children with hypoprothrombinemia-lupus anticoagulant syndrome (HLAS) and its application research.

Lupus·2026
Same journal

T-bet expression in B cell subsets: Association with T peripheral helper cells and clinical activity in systemic lupus erythematosus.

Lupus·2026
Same journal

Autonomic dysfunction in systemic lupus erythematosus and systemic sclerosis.

Lupus·2026
See all related articles

Equivalence trials aim to demonstrate that two treatments yield similar outcomes, offering advantages like reduced toxicity or cost. This approach is crucial for evaluating drug safety and comparing treatments when absolute equality cannot be proven.

Area of Science:

  • Clinical Trials
  • Biostatistics
  • Pharmacoeconomics

Background:

  • Most clinical trials aim to prove treatment superiority.
  • Equivalence trials assess if treatments are similar or marginally different.
  • This is valuable for treatments with benefits like lower toxicity or cost.

Purpose of the Study:

  • To explain the methodology of equivalence trials.
  • To discuss planning, conduct, and analysis of equivalence trials.
  • To provide examples from the SELENA study in the context of SLE.

Main Methods:

  • Equivalence trials define an acceptable margin of difference between treatments.
  • They assess if the true treatment difference falls within this margin.
  • The classical null hypothesis of equality is not used.

Related Experiment Videos

Main Results:

  • Equivalence trials are essential for comparing treatments with practical advantages.
  • They are also key in safety evaluations, showing similar adverse event risks.
  • The SELENA study provides practical examples of these methods.

Conclusions:

  • Equivalence trials offer a distinct and valuable framework for clinical research.
  • They are particularly relevant for treatments offering non-inferior efficacy with added benefits.
  • Proper planning and analysis are critical for valid equivalence trial conclusions.